U.S. Physical Therapy (USPH) Aandelenoverzicht
U.S. Physical Therapy, Inc. exploiteert en beheert samen met haar dochterondernemingen poliklinieken voor fysiotherapie. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 3/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 1/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 3/6 |
USPH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
U.S. Physical Therapy, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$80.05 |
| 52 Week Hoogtepunt | US$93.50 |
| 52 Week Laag | US$58.19 |
| Bèta | 1.13 |
| 1 maand verandering | 10.35% |
| 3 maanden verandering | 34.72% |
| 1 Jaar Verandering | -8.70% |
| 3 jaar verandering | -26.96% |
| 5 jaar verandering | -28.38% |
| Verandering sinds IPO | 3,212.41% |
Recent nieuws en updates
Recent updates
U.S. Physical Therapy Continues To Heal
Summary U.S. Physical Therapy, Inc. remains rated Hold as operational growth is offset by disappointing profitability and fair valuation. USPH exceeded revenue expectations in Q2 2026, but EPS fell short due to one-time events and rising costs. Clinic expansion, hospital affiliations, and industrial injury prevention services are driving top-line growth and future margin improvement. Despite improving fundamentals and ongoing acquisitions, USPH trades at higher multiples than most peers, limiting near-term upside. Read the full article on Seeking AlphaU.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) is back in focus after recent financial disclosures showed 7.89% year-over-year revenue growth and net profit rising 115.29%, while analyst opinions and technical signals currently point in different directions for the stock. See our latest analysis for U.S. Physical Therapy. Despite the latest revenue and net profit figures, U.S. Physical Therapy’s 1-year total shareholder return declined 12.6% and the 5-year total shareholder return fell 41.7%, indicating fading...
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have lowered their price target on U.S. Physical Therapy to $90 from $103, citing somewhat lower profitability expectations and a higher projected net debt load following a mixed Q1 report. What's in the News From January 1, 2026 to March 31, 2026, U.S. Physical Therapy reported no share repurchases, with 0 shares bought for US$0 million under its existing buyback program (Key Developments).USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.These 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...Rendement voor aandeelhouders
| USPH | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | 1.3% | -0.2% | 4.2% |
| 1Y | -8.7% | 40.5% | 20.6% |
Rendement versus industrie: USPH presteerde slechter dan de US Healthcare -sector, die het afgelopen jaar een rendement van 40.5 % opleverde.
Rendement versus markt: USPH presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 20.6 % opleverde.
Prijsvolatiliteit
| USPH volatility | |
|---|---|
| USPH Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: USPH heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van USPH is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1990 | 6,374 | Chris Reading | www.usph.com |
U.S. Physical Therapy, Inc. exploiteert en beheert, samen met haar dochterondernemingen, poliklinieken voor fysiotherapie. Het bedrijf opereert via twee segmenten, Fysiotherapiewerkzaamheden en Industriële letselpreventiediensten. Het bedrijf biedt pre- en postoperatieve zorg en behandeling voor orthopedische aandoeningen, sportblessures, preventieve zorg, revalidatie van gewonde werknemers en neurologische blessures.
U.S. Physical Therapy, Inc. Samenvatting
| USPH fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$1.19b |
| Inkomsten(TTM) | US$2.66m |
| Inkomsten(TTM) | US$804.27m |
Is USPH overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| USPH resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$804.27m |
| Kosten van inkomsten | US$631.62m |
| Brutowinst | US$172.65m |
| Overige uitgaven | US$169.99m |
| Inkomsten | US$2.66m |
Laatst gerapporteerde inkomsten
Jun 30, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.18 |
| Brutomarge | 21.47% |
| Nettowinstmarge | 0.33% |
| Schuld/Eigen Vermogen Verhouding | 28.7% |
Hoe presteerde USPH op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
Betaalt USPH een betrouwbaar dividend?
Zie USPH dividendgeschiedenis en benchmarks| U.S. Physical Therapy dividenddata | |
|---|---|
| Ex Dividend Datum | Aug 21 2026 |
| Betaaldatum dividend | Sep 11 2026 |
| Dagen tot Ex-dividend | 11 days |
| Dagen tot dividendbetaaldatum | 32 days |
Betaalt USPH een betrouwbaar dividend?
Zie USPH dividendgeschiedenis en benchmarksBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/08/09 19:51 |
| Aandelenkoers aan het einde van de dag | 2026/08/07 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
U.S. Physical Therapy, Inc. wordt gevolgd door 15 analisten. 7 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |